[1]
M.-I. Pereira, “Targeted-delivery of chemotherapy (NANOLEUK) vs standard chemotherapy in acute myeloid leukemia: a proposed randomized, double-blinded, multicenter efficacy trial”, PPCR, vol. 2, no. 2, Nov. 2016.